
































































are	 biologically	 ‘older’	 than	 their	 unaffected	 peers.	 This	 is	 most	 obviously	 seen	 with	
cardiovascular	disease:	young	patients	on	haemodialysis	have	a	relative	risk	of	cardiovascular	
mortality	 similar	 to	 that	 of	 people	 over	 50	 years	 their	 senior	 in	 the	 general	 population.	
Moreover,	 there	 are	 striking	 analogies	 between	 the	 effects	 of	 physiological	 ageing	 and	
uraemia	on	the	structure	and	function	of	the	heart	and	vasculature.	Despite	this,	little	work	





was	 to	 investigate	whether	 autophagy	 and	 senescence	 are	 indeed	 altered	 in	 the	 uraemic	
heart,	whether	these	processes	might	be	linked,	and	whether	the	findings	of	these	enquiries	





subtotal	 (5/6)	 nephrectomy	 rodents.	 Autophagy	 was	 assayed	 using	 immunoblotting,	 PCR	
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Ageing	is	a	time-dependent,	progressive	 loss	of	physiological	 integrity,	 leading	to	 impaired	
function	and	increased	vulnerability	to	death2.		Dialysis	dependent	CKD	patients	of	any	age	
have	 an	 increased	 risk	 of	 mortality	 when	 compared	 to	 kidney	 transplant	 recipients	 and	
healthy	controls	of	the	same	age3,	and	are	more	susceptible	to	disease,	particularly	that	of	








mortality,	whilst	 simultaneously	being	a	 chronic	 inflammatory	 state,	 a	pattern	of	 immune	
dysfunction	also	associated	with	ageing6.		These	abnormalities	also	seem	to	be	reflected	at	a	
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Cellular	 senescence	 was	 originally	 described	 by	 Hayflick	 in	 serially	 passaged	 human	
fibroblasts,	which	undergo	a	certain	number	of	divisions	(the	’Hayflick	limit’)	before	entering	
a	 senescent	 phase15.	 This	 phenomenon	 was	 subsequently	 shown	 to	 be	 due	 to	 telomere	
shortening16.	Replicative	DNA	polymerases	are	unable	to	fully	replicate	the	terminal	ends	of	
linear	DNA	molecules,	this	function	being	restricted	to	a	specialized	DNA	polymerase	known	
as	 telomerase.	 Most	 mammalian	 somatic	 cells	 do	 not	 express	 telomerase,	 with	 the	
consequence	 that	 there	 is	 a	 progressive	 loss	 of	 protective	 telomere	 sequences	 from	
chromosome	ends2,17.	This	eventually	exposes	an	uncapped	double-stranded	chromosome	





prevented	 from	 entering	 into	 the	 S	 phase	 of	 the	 cell	 cycle18,19,20,21.	 A	 second	 barrier	 to	
proliferation,	p16Ink4a	prevents	CDK4-	and	CDK6-mediated	inactivation	of	RB	to	block	cell	cycle	
progression.	 This	 mechanism	 can	 act	 either	 alone	 or	 in	 combination	 with	 the	 p53-p21	
pathway18.	Both	p14ARF	and	p16Ink4a	are	encoded	for	by	the	gene	CDKN2a,	thus	activation	of	

























or	 increased	 lifespans	 respectively28,29,	 and	 the	 premature	 ageing	 of	 telomerase-deficient	
mice	can	be	reversed	with	genetic	reactivation	of	telomerase30.	Physiological	ageing	in	adult	
wild-type	mice	can	be	delayed	by	viral	transduction	of	telomerase31.	Telomerase	deficiency	
in	 humans	 is	 associated	with	 the	 premature	 development	 of	 diseases	 such	 as	 pulmonary	
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cardiovascular	 diseases	 and	 Alzheimer’s	 disease33.	 Mutant	 mice	 with	 premature	 ageing	












primary	 protein	 degradation	 systems	 (the	 ubiquitin-proteasome	 and	 autophagy-lysosome	
systems),	 have	 all	 been	 determined	 to	 decline	 with	 ageing2.	 	 Experimentally	 increasing	





The	 term	 ‘autophagy’,	 derived	 from	 the	 Greek	meaning	 ‘eating	 of	 self’	 was	 first	 used	 by	
Christian	de	Duve	in	the	Journal	of	Cell	Biology	in	1967,	when	describing	the	degradation	of	
mitochondria	and	other	intra-cellular	structures	within	lysosomes	of	rat	liver	perfused	with	
glucagon41.	 Autophagy	 has	 traditionally	 been	 divided	 into	 macro-autophagy,	 micro-
autophagy	 and	 chaperone-mediate	 autophagy	 (CMA)42.	 Micro-autophagy	 refers	 to	 the	
process	by	which	structures	in	the	cytoplasm	are	taken	up	directly	by	the	lysosome42.	In	CMA	
proteins	are	carried	into	lysosomes	in	complexes	with	chaperone	proteins	that	are	recognized	









these	 pathways.	Whilst	 it	 often	 constitutes	 a	 stress	 response	 that	 avoids	 cell	 death	 (and	
suppresses	apoptosis),	under	certain	circumstances	it	may	constitute	an	alternative	cell	death	
pathway.	Autophagy	and	apoptosis	may	be	triggered	by	common	upstream	signals	resulting	





















in	 a	 double-membraned	 vesicle	 named	 an	 autophagosome50.	 This	 autophagosome	
subsequently	 fuses	with	 a	 lysosome	 to	 form	 an	 autolysosome,	 the	 contents	 of	which	 are	
	 25	
broken	down	by	 lysosomal	enzymes42.	Amino	acids	and	other	products	of	degradation	are	
exported	back	out	 to	 the	 cytoplasm	via	 lysosomal	permeases	and	 transporters,	 for	use	 in	
building	macromolecules	and	metabolism50.		
	
A	 key	 component	 of	 the	 autophagosome	 is	 LC3-II,	 which	 is	 composed	 of	 a	 protein,	











sources	 have	 been	 suggested,	 including	 endoplasmic	 reticulum	 (ER)	 and	 the	 Golgi52.	 The	
initiation	 process	 depends	 upon	 the	 action	 of	 the	 Class	 III	 phosphatidylinositol-4,5-
biphosphate	 3-kinase	 (PI3	 kinase)	 VPS34,	 which	 converts	 phosphatidylinositol	 to	


















The	 initiation	 complex	 generates	PI3P	at	 the	 site	of	 formation	of	 the	 isolation	membrane	 (or	phagophore),	 leading	 to	 the	binding	of	PI3P	binding	proteins	and	 the	
recruitment	of	proteins	involved	in	the	‘elongation	reaction’	to	the	isolation	membrane	4)	In	the	elongation	reaction	the	phosphatidylethanolamine-conjugated	form	of	









for	 autophagy	 induction	 is	 reduced	 in	 aged	 tissues,	 and	 that	 autophagy	 diminishes	 with	
ageing56.	For	example,	ATG5,	ATG7,	and	beclin	1	have	been	shown	to	be	downregulated	in	
physiologically	aged	human	brains57.	Tissue-specific	knockout	of	Atg	genes	precipitates	age-
associated	 stigmata	 in	 mice:	 these	 include	 the	 accumulation	 of	 ubiquitinylated	 protein-
containing	inclusion	bodies,	the	appearance	of	the	ageing	pigment	lipofuscin	in	lysosomes,	
disorganized	 mitochondria,	 and	 the	 oxidation	 then	 carbonylation,	 carboxymethylation	 or	
nitrosylation	 of	 proteins56.	 Zhang	 and	 Cuervo	 created	 an	 inducible	 hepatocyte-specific	
LAMP2a	transgene	to	arrest	the	decline	in	LAMP2a	levels	in	ageing	mice.	This	restored	defects	
in	autophagy,	and	reduced	the	presence	of	oxidised	proteins	and	polyubiquinated	protein	
aggregates58.	The	observation	by	Melendez	et	al.	 that	 inhibition	of	 the	 insulin-like	growth	
factor	 pathway	 stimulates	 autophagy	 in	 C.elegans	 and	 that	 inhibition	 of	 autophagy	 by	
mutation	of	Atg	genes	prevents	gain	of	longevity	was	the	first	to	associate	autophagy	with	
longevity59.	 Caloric	 restriction	 (CR,	 reduced	 food	 intake	without	malnutrition)	 extends	 life	




In	 postmitotic	 cells	 there	 is	 no	 cell	 division-mediated	 ‘dilution’	 of	 intracellular	 debris,	
therefore	autophagy	makes	an	important	contribution	to	protein	homeostasis	and	organelle	
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The	 mitochondrial	 theory	 of	 ageing	 suggests	 that	 ageing	 results	 from	 accumulating	
mitochondrial	 damage	 leading	 to	 progressive	 mitochondrial	 uncoupling	 with	 consequent	
bioenergetics	 insufficiency	 and	 increased	 production	 of	 reactive	 oxygen	 species	 (ROS)64.	
Autophagy	inhibition	results	in	deteriorated	mitochondrial	function	in	mice65.		
	
Autophagy	 may	 play	 a	 role	 in	 hormesis,	 the	 phenomenon	 whereby	 cells,	 organs,	 and	
organisms	 are	 able	 to	 resist	 typically	 lethal	 conditions	 after	 they	 have	 been	 exposed	 to	
sublethal	damage56.		One	example	of	this	is	ischaemic	preconditioning,	wherein	the	exposure	
of	 tissues	 to	 short	episodes	of	 ischaemia	 subsequently	protects	 them	against	 infarction56.	












Autophagy	 limits	 inflammatory	reactions	through	several	mechanisms.	Autophagy	 in	dying	
cells	 is	 required	 for	 clearing	of	apoptotic	 corpses,	 thus	 reducing	 inflammatory	 reactions70.	
Impaired	 autophagy	 results	 in	 the	 accumulation	 of	 p62/STQM1,	 which	 can	 activate	 the	
proinflammatory	 transcription	 factor	NF-KB	and	 the	 stress-responsive	 transcription	 factor	
NRF2,	 resulting	 in	 inflammation	and	tissue	 injury71.	Autophagy	also	 limits	 inflammation	by	
eliminating	 dysfunctional	 mitochondria72,	 and	 because	 pathological	 ageing	 is,	 commonly,	













have	 potentially	 cytoprotective	 or	 cytotoxic	 functions)	 would	 suggest	 some	 form	 of	 co-
existence,	but	if	and	how	they	work	alongside	one	another	remains	to	be	fully	elucidated75.	
Several	 investigators	 have	 provided	 indirect	 evidence	 for	 the	 simultaneous	 induction	 of	
autophagy	and	senescence	(for	example,	an	increase	in	numbers	of		autophagic	vacuoles	and	
senescence-associated	b-galactosidase	activity	has	been	observed	in	ageing	fibroblasts76),	but	
these	 studies	 do	 not	 address	 whether	 autophagy	 and	 senescence	 are	 linked	 or	
interdependent.		
	
















conditions	between	studies,	 there	has	hitherto	been	a	 lack	of	consensus	as	 to	 if	and	how	
autophagy	and	senescence	influence	one	another.	
Very	recent	reports	have	suggested	that	autophagy	may	modulate	several	targets	that	act	in	
opposition	 to	 regulate	senescence.	Thus,	autophagy	 inhibition	or	promotion	may	 result	 in	
different	 outcomes	 depending	 on	 the	 timing,	 duration,	 or	 type	 of	 its	 inhibition79.	 The	
transcription	factor	GATA4	is	a	key	regulator	of	the	SASP	and	senescence,	and	its	stability	is	
regulated	by	autophagy.	Sequestosome	1/p62	(SQSTM1/p62,	henceforth	referred	to	as	p62)	
mediates	 the	 degradation	 of	 GATA4	 under	 normal	 conditions.	 However,	 once	 the	 cell	
experiences	senescence-inducing	stimuli,	the	interaction	between	GATA4	and	p62	decreases,	
and	GATA4	escapes	from	autophagic	 inhibition	and	accumulates.	This	accumulated	GATA4	
initiates	 a	 transcriptional	 circuit	 to	 activate	 NKKB/NF-kB	 and	 the	 SASP80.	 Kang	 et	 al	
demonstrated	that	transient	inhibition	of	autophagy	using	an	inducible	small	interfering	RNA	
(siRNA)	 system	 stimulated	 senescence	 more	 than	 continuous	 inhibition,	 and	 that	 p62	
depletion	induces	cellular	senescence	more	than	depletion	of	autophagy	regulators	ATG7	or	
ATG5.	The	authors	suggest	that	selective	autophagy	suppresses	cellular	senescence	through	
the	 breakdown	 of	 GATA4,	 whereas	 general	 autophagy	 supports	 senescence	 transition	
through	the	TOR-autophagy	spatial	coupling	compartment	(TASCC)79.	Thus	autophagy	can	act	
through	either	an	anti-	or	prosenescence	mechanism	depending	on	its	type	of	regulation.		














an	 important	 and	 protective	 role	 in	 a	 growing	 number	 of	 physiological	 and	 pathological	
processes,	including	the	immune	response70,	regulation	of	the	inflammatory	response71,	and	
the	prevention	of	malignancy84.	Whilst	the	involvement	of	autophagy	in	the	genesis	of	kidney	
injury	 and	 disease	 has	 been	 the	 subject	 of	 investigation	 and	 review	 in	 the	 scientific	
literature85,	very	little	work	has	been	done	looking	at	the	effect	of	kidney	failure	on	autophagy	
in	other	tissues.		
Uraemic	 individuals	 exhibit	 an	 increased	 susceptibility	 to	 numerous	 disease	 processes	 in	
which	autophagy	is	thought	to	have	a	protective	role,	in	addition	to	their	accelerated	ageing	
phenotype.	As	mentioned	earlier,	patients	with	CKD	are	known	to	have	an	increased	rate	of	
infectious	 and	 cardiovascular	 morbidity	 and	 mortality	 when	 compared	 to	 age-	 matched,	
healthy	controls4,6.	Using	a	rodent	model	of	CKD	and	myocardial	 infarction,	our	group	has	
previously	 demonstrated	 that	 uraemia	 reduces	 ischaemia	 tolerance	 and	 increases	 infarct	




to	 have	 a	 protective	 function	 in	 these	 pathologies,	 it	 is	 possible	 that	 a	 perturbation	 of	
autophagy	may	contribute	to	their	development,	and	that	this	may	play	a	role	in	the	tendency	
of	uraemic	patients	to	develop	them:	autophagy	is	dysfunctional	in	uraemia.	





the	 effect	 of	 rapamycin	 administration	 in	 a	 murine	 model	 of	 normotensive	 uraemic	
cardiomyopathy.	Treatment	of	surgically	induced	renal	injury	mice	with	rapamycin	blocked	
the	development	of	cardiac	hypertrophy	and	fibrosis	when	compared	with	vehicle-treated	
animals90.	 The	 experimenters	 suggest	 that	 this	 protective	 effect	 is	 mediated	 by	 the	
extracellular	signal-regulated	kinase	and	mammalian	mTOR	pathways,	but	do	not	speculate	
on	the	possible	involvement	of	autophagy.	They	do,	however,	raise	the	interesting	question	
of	whether	 renal	 transplant	 recipients	 taking	 rapamycin	as	an	 immunosuppressant	exhibit	









Some	 studies	 have	 investigated	 the	 possible	 role	 of	 senescence	 and	 telomere	 attrition	 in	
uraemia.	Jiminez	et	al.		looked	at	markers	of	senescence	in	circulating	immune	cells	in	uraemic	
pre-dialysis,	 haemodialysis-dependent	 and	 transplanted	 patients.	 Abnormal	 telomere	
shortening	was	 detected	 in	 immune	 cell	 subpopulations	 in	 pre-dialysis	 and	haemodialysis	
patients	who	dialyzed	with	cellulosic	membranes,	but	also	in	transplant	recipients	with	near	
normal	 renal	 function91.	 It	 was	 thus	 unclear	 as	 to	 whether	 telomere	 shortening	 and	
immunosenescence	was	the	result	of	uraemia	per	se	or	 from	chronic	 inflammation	due	to	
kidney	 disease,	 a	 bio-	 incompatible	 dialysis	 membrane,	 or	 in	 the	 case	 of	 the	 transplant	
patients	 due	 to	major	 histocompatibility	 complex	 incompatibility	 and	 immunosuppressive	
therapy.	 Tsirpanlis	 et	 al.	 	 measured	 the	 activity	 of	 telomerase	 in	 peripheral	 blood	










Several	 groups	 have	 looked	 at	 the	 role	 of	 senescence	 in	 the	 endothelial	 dysfunction	
associated	 with	 cardiovascular	 disease	 in	 uraemia.	 	 Adijiang	 et	al.	 	 administered	 indoxyl	
	 36	
sulphate	(IS,	a	uraemic	toxin)	to	rats	and	examined	their	aorta	for	evidence	of	senescence.			
Treated	animals	 showed	 significantly	 increased	aortic	 calcification	and	wall	 thickness,	 and	
significantly	 increased	 expression	 of	 SA-	 β-gal,	 p16Ink4a,	 p21,	 p53	 and	 pRb	 in	 cells	 in	 the	
calcified	 area94.	 The	 same	 group	went	 on	 to	 demonstrate	 that	 uraemic	 toxins	 stimulated	




obtained	 from	 healthy	 volunteers.	 	 EPCs	 were	 exposed	 to	 low-density	 lipoprotein	 (LDL)	
generated	after	incubation	of	native	LDL	(nLDL)	with	uraemic	serum	from	patients	with	CKD	
stages	 2-4.	 Compared	 with	 nLDL,	 the	 uraemic	 serum-treated	 LDL	 induced	 an	 increase	 in	



















Identifying	 and	 isolating	 senescent	 cells	 in	 vivo	 is	 a	 major	 challenge.	 Senescent	 cells	 are	
thought	 to	accumulate	 in	aged	tissues	based	on	the	detection	of	cells	with	high	SA-b-GAL	
activity	and	expression	of	p53,	p21,	pRB	and	p16Ink4a.	However,	the	relative	rarity	of	these	







Autophagy	 is	 a	 notoriously	 elusive	 process	 to	 assay	 due	 to	 its	 complex	 spatiotemporal	
mechanics,	and	its	responsiveness	to	multiple,	subtle	variables	
‘Autophagic	 flux’	 refers	 to	 the	 complete	 process	 of	 autophagy,	 which	 begins	 with	 the	




















exhibit	 different	 tissue	 distributions,	 A,	 B,	 B2	 and	 C,	 with	 LC3B	 being	 most	 commonly	
utilised99.	 LC3	 is	 initially	 synthesized	 in	 an	 unprocessed	 form,	 proLC3,	 with	 a	 C-terminal	
extension	that	 is	removed	by	the	protease	ATG4	and	becomes	LC3-I.	LC3-I	 is	subsequently	
conjugated	with	PE	by	an	enzymatic	reaction	to	become	LC3-II.	Whereas	LC3-I	is	localized	in	
the	 cytoplasm,	 LC3-II	 associates	 with	 both	 the	 outer	 and	 inner	 membranes	 of	







LC3-I	 and	 LC3-II	 are	 detected	 as	 two	 separate	 bands	 following	 gel	 electrophoresis	 and	
immunoblotting.	ProLC3	is	not	detected	under	normal	conditions	as	ATG4	processes	it	into	
LC3-I	immediately	after	synthesis102.	Although	the	molecular	weight	of	LC3-II	is	greater	than	























during	 starvation	 (a	 potent	 autophagy-inducer)	 in	 wild-type	mouse-embryonic	 fibroblasts	














been	developed	to	simultaneously	monitor	 the	 transcriptional	 regulation	of	all	 (or	a	great	














lysosome99.	However,	 interpreting	 TEM	 images	 requires	 a	 degree	of	 expertise	 in	 order	 to	
distinguish	autophagosomes	from	other	cellular	membranous	structures.		




LC3	 can	be	 labelled	by	using	GFP-LC3	 (green	 fluorescent	protein-LC3)	 transfected	mice111.	
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Another	approach,	which	eliminates	the	costs	and	difficulties	 inherent	 in	transfection,	and	




associated	 with	 this	 technique	 is	 the	 problem	 localizing	 LC3	 to	 autophagic	 vacuoles,	 as	
opposed	to	the	cytoplasm,	thus	immunohistochemistry	for	LC3	cannot	be	used	on	its	own	as	





The	 term	 ‘uraemia’	 is	 used	 to	 describe	 the	 constellation	 of	 pathophysiological	 changes	
accompanying	loss	of	kidney	function,	rather	than	just	the	accumulation	of	nitrogenous	waste	
products	 in	 the	 blood.	 It	 is	 a	 heterogenous	 syndrome	 that	 includes	 hypertension,	 left	
ventricular	 hypertrophy	 (LVH),	 disturbances	 in	 bone	 biochemistry,	 vascular	 calcification,	








Several	 experimenters	 have	 attempted	 to	 create	 a	 ‘uraemic	milieu’	 by	 incubating	 cells	 in	
culture	medium	 supplemented	with	 serum	 from	 uraemic	 animals,	 with	 serum	 from	 non-	
uraemic	animals	used	as	a	control113.	Alternatively	selected	‘uraemic	toxins’,	such	as	indoxyl	
sulphate	 (IS)	 can	 be	 used	 singularly	 or	 in	 combination	 to	 simulate	 the	 uraemic	











account.	 For	 example,	 it	 is	 generally	 held	 that	 animals	 do	 not	 particularly	 enjoy	 certain	
experimental	diets,	and	are	thus	relatively	calorie-deprived	compared	to	animals	fed	a	control	








Yokazawa	 et	 al.	 first	 described	 the	 use	 of	 supplemental	 adenine	 to	 generate	 a	model	 of	
uraemia	 in	 1986115.	 Following	 a	 diet	 supplemented	 with	 0.75%	 adenine	 for	 30	 days	 rats	
developed	a	uraemic	phenotype.	Histological	examination	of	the	kidneys	revealed	granuloma	
around	crystalline	deposits	 in	the	tubules	and	interstitium,	along	with	evidence	of	marked	





Adenine	 is	 metabolised	 to	 adenosine	 monophosphate	 (AMP)	 via	 the	 enzyme	 adenine	









This	 is	 created	by	a	 two-stage	surgical	procedure,	whereby	2/3rd	of	one	kidney	 is	 initially	
removed	 followed,	 two	weeks	 later,	by	a	 contralateral	nephrectomy	 (leaving	1/6th	of	 the	
original	 nephron	mass	 remaining).	 Histological	 examination	 of	 the	 remnant	 kidney	 shows	
hypercellular	glomerular	tufts,	with	expansion	of	the	glomerular	volume	and	tubular	atrophy.	
The	 serum	 creatinine	 rise	 is	 less	 than	 that	 in	 the	 adenine	 diet	 model,	 but	 subtotal	





The	 molecular	 biology	 of	 ageing	 is	 extraordinarily	 complex,	 and	 remains	 incompletely	
understood.	It	is	likely	that,	rather	than	operating	in	isolation,	the	‘hallmarks	of	ageing’	are	
interlinked	 and	 interdependent,	 and	 the	 cellular,	 tissue	 and	 organismal	 changes	 that	




The	 striking	 similarities	 between	 the	physiologically	 aged	 and	uraemic	 phenotypes,	whilst	
much	commented	upon,	has	been	little	investigated	at	a	cellular	nor	molecular	level.	One	of	











Cardiac	 changes	are	amongst	 the	most	 striking	 seen	 in	both	physiological	 ageing	and	end	
stage	 renal	 failure.	 These	 include	 loss	 of	 functioning	 cardiac	myocytes	 and	 compensatory	
hypertrophy	of	remaining	cells,	myocardial	fibrosis,	and,	as	a	result,	thickening	and	stiffening	
of	 the	myocardium118,119.	 Interestingly,	 the	 suggested	driving	 forces	 for	 these	changes	are	
similar	for	both	ageing	and	uraemia,	with	enhanced	inflammatory	activity	and	oxidative	stress	
seen	in	both	‘conditions’119,120.	Moreover,	cardiac	death	remains	the	single	greatest	cause	of	
mortality	 in	 patients	 (adult	 and	 paediatric)	 with	 advanced	 kidney	 disease121,122.	 Whilst	





in	 cardiac	 failure	 in	 the	 elderly	 has	 been	 proposed124,125.	 	 Our	 group	 has	 an	 interest	 and	
experience	in	cardiac	disease	in	uraemia,	and	has	established	an	in	vivo	rat	model	of	uraemic	
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untangle,	 and	 even	 more	 so	 to	 recreate	 in	 a	 controlled	 experiment.	 Furthermore,	 both	
autophagy	and	senescence	are	difficult	to	detect,	monitor	and	manipulate,	and	are	affected	



































































Rapamycin	 (Enzo	 Life	 Sciences,	 Exeter,	 Devon,	 UK)	 was	 dissolved	 in	 dimethyl	 sulfoxide	
(DMSO)	(Fisher	Scientific,	Loughborough,	Leicestershire,	UK)	to	produce	a	200	µM	solution.	
Volumes	of	this	solution	were	added	to	cell	culture	wells	to	achieve	100,	250,	500	nM	and	1	































contents	 were	 transferred	 to	 Eppendorf	 tubes	 (Eppendorf™,	 Hamburg,	 Germany)	 and	
centrifuged	at	16,000	g	for	10	min	at	4°C.	The	supernatant	from	each	Eppendorf	tube	was	














buffer	 (Novex™,	 Life	 Technologies)	 mixture	 (1:2.5	 ratio).	 For	 other	 samples,	 the	 volume	
















1	 litre	of	 transfer	buffer	was	prepared	using	 (for	one	membrane)	850	mL	reverse	osmosis	
water,	50	mL	(20	x)	NuPAGE	transfer	buffer	(Novex™,	Life	Technologies),	100	mL	methanol	
and	1	mL	antioxidant.	This	was	used	to	soak	filter	papers	and	blotting	pads.	A	0.45	µM	pore	
size	 polyvinylidene	 fluoride	 (PVDF)	membrane	 (Fisher	 Scientific)	 was	 pre-soaked	 in	 100%	
methanol.	The	gel	was	carefully	 removed	and	placed	on	a	 filter	paper,	 then	placed	 in	 the	



















peroxidase	 (Cell	 Signaling)	 at	 a	 dilution	 of	 1:2000.	 A	 further	 three	washes	 of	 TBS-T	were	
performed,	 then	 protein	 bands	 visualised	 using	 ECL	 Prime	 Western	 Blotting	 Detection	
Reagent	(GE	Healthcare)	on	ECL	X-ray	film	(GE	Healthcare).	Protein	loading	was	checked	using	


































After	 1	week	 acclimatisation	 rats	were	 anaesthetised	with	 inhaled	1.5%	 isofluran	 (Baxter,	
Newbury,	Berkshire,	UK).	The	fur	on	the	left	flank	was	shaved	and	a	1	cm	incision	was	made	
just	inferior	to	the	lower	margin	of	the	rib	cage.	The	flank	musculature	was	blunt	dissected	
and	 the	 parietal	 peritoneum	was	 cut.	 The	 left	 kidney	was	 then	 externalised	 through	 the	
incision.	The	perinephric	fat	and	renal	capsule	were	removed	and	an	arterial	clamp	placed	
around	the	renal	artery	and	vein.	3	sections	of	renal	parenchyma	were	removed:	the	upper	



































allowing	 punctae	 associated	 with	 autophagosomes	 to	 be	 visualised	 under	 fluorescent	
microscopy)	 were	 kindly	 provided	 by	 Dr	 Norburu	Mizushima	 at	 Tokyo	Medical	 &	 Dental	
University,	Japan	(genetic	background	C57BL/6J).		
	
Homozygote	 x	 heterozygote	 and	homozygote	 x	wild	 type	 systems	were	 used	 to	 generate	
heterozygotes	for	experiment.	Heterozygote	x	wild	type	was	used	when	littermate	controls	
were	required.	The	PCR	protocol	below	is	currently	unable	to	identify	between	wild	type	and	






















































effort	 to	 control	 for	 the	 effects	 of	 nutrient	 intake	 on	 autophagy	 activation.	 4	 h	 prior	 to	
sacrifice	half	of	the	experimental	and	control	groups	received	an	intraperitoneal	injection	of	






and	 either	 snap	 frozen	 in	 liquid	 nitrogen	 (for	 western	 blotting,	 PCR	 or	 b-galactosidase	













































































6,	 this	was	not	 recommended	 in	Qiagen’s	product	 literature	as	 the	arrays	already	contain	































































Tissues	 were	 harvested	 from	 animals	 and	 placed	 in	 10%	 formalin	 for	 24	 h	 before	 being	









Mice	 were	 anaesthetized	 as	 described	 previously.	 The	 heart	 was	 exposed	 by	 midline	
sternotomy,	and	12	mL	of	chilled,	4%	paraformaldehyde	(PFA)	 in	PBS	 infused	 into	the	 left	
ventricle	over	3	min	via	cardiac	puncture.	Tissues	were	subsequently	excised	and	washed	in	
4%	PFA,	 then	 immersed	 in	 4%	PFA	overnight	 at	 4˚C.	 Tissues	were	 then	 immersed	 in	 15%	
sucrose	in	PBS	for	4	h,	followed	by	30%	sucrose	in	PBS	overnight.	Tissues	were	embedded	in	



























Images	 were	 analysed	 using	 a	 free,	 downloadable	 plugin	 for	 Image	 J	











and	 sectioned	 at	 4	 µm.	 Sections	 were	 collected	 on	 glass	 slides	 and	 air	 dried	 at	 room	
temperature	for	30	min,	then	fixed	in	1%	formalin	in	PBS	at	room	temperature	for	1	min.	They	
were	then	gently	washed	in	PBS	and	immersed	overnight	in	β-Gal	staining	solution	(supplied	













































Chloroquine	accumulates	 in	acidic	 lysosomes	and	 increases	the	 lysosomal	pH.	This	 inhibits	
lysosomal	hydrolases	and	prevents	autophagosomal	fusion	and	degradation127.	Chloroquine	






Increasing	 the	 concentration	 of	 chloroquine	 in	 full	 media	 for	 the	 final	 6	 h	 of	 incubation	
resulted	 in	 an	 increase	 in	 the	 amount	 of	 LC3B-II	 and	 p62	 detected	 in	 H9c2	 cells.	 A	
concentration	 range	 of	 10-25	 µmol/L	 of	 was	 henceforth	 chosen	 for	 further	 work	 as	 the	



































the	highest	concentration	of	 rapamycin	 tested	 (100	nmol/L,	 suggesting	an	 indefinite	dose-
response	effect),	but	in	the	presence	of	chloroquine	this	effect	was	reversed	(there	being	less	
LC3B-II	in	cells	exposed	to	rapamycin	at	this	dose	than	in	those	exposed	to	none).	It	is	thus	
possible	 to	 speculate	 that	 at	 very	 high	 concentrations	 rapamycin	 may	 actually	 inhibit	
autolysosomal	degradation.	Interestingly	rapamycin	seemed	to	have	very	little	effect	on	the	
amount	of	p62	detected.		One	would	expect	the	expression	of	p62	to	reflect	the	upregulation	







































depleted,	 therefore	 it	was	 important	 to	 assess	 the	 effect	 of	 this	 on	 autophagy	 in	 cardiac	
myocytes	as	a	potential	confounder	which	would	need	to	be	corrected	for.		
	
It	 was	 decided	 to	 investigate	 the	 effect	 of	 glucose	 on	 autophagy	 in	 cardiac	 myocytes	 in	
conditions	 of	 serum	 starvation:	 in	 addition	 to	 bovine	 serum	 albumin	 (BSA),	 FCS	 contains	












upregulation	of	autophagy.	 	However,	 it	 is	 important	to	note	that	p62	was	also	 increased,	
suggesting	that	this	increase	may	be	due	to	an	accumulation	of	autophagosomes	that	are	not	
subsequently	broken	down,	rather	than	an	accelerated	production.	This	seems	to	have	been	





























































concentration	of	10	µmol/L	 for	 the	 last	4	h	of	 incubation.	LC3B	and	p62	were	resolved	by	
immunoblot	(Figures	7	and	8).	
	
Incubating	cells	 in	media	containing	 increasing	concentrations	of	 indoxyl	 sulphate	 for	24	h	
produced	a	concentration-dependent	increase	in	the	amount	of	LC3B-II	up	to	and	including	a	
dose	 of	 50	 µg/mL,	 suggesting	 an	 increase	 in	 autophagy	 initiation	 (Figure	 7).	 This	 was	
corroborated	 by	 the	 addition	 of	 chloroquine,	 which	 did	 not	 reverse	 the	 pattern,	 thus	






Incubating	 cells	 in	media	 containing	 the	 same	concentrations	of	 indoxyl	 sulphate	 for	48	h	
resulted	 in	 a	 similar	 pattern	 of	 LC3B-II	 detection,	 with	 the	 amount	 of	 LC3B-II	 particularly	






































without	 chloroquine.	 B:	 Graph	 showing	 densitometry	 of	 LC3BII	 band	 relative	 to	 that	 of	 GAPDH	 at	
increasing	 concentrations	 of	 indoxyl	 sulphate	 at	 24	 h	 without	 chloroquine.	 C:	 Graph	 showing	
densitometry	of	LC3BII	band	relative	to	that	of	GAPDH	at	increasing	concentrations	of	indoxyl	sulphate	
at	24	h	with	 chloroquine.	D:	Graph	 showing	densitometry	of	p62	band	 relative	 to	 that	of	GAPDH	at	































A:	 Western	 blot	 showing	 bands	 reactive	 with	 LC3B,	 p62	 and	 GAPDH	 at	 increasing	 concentrations	 of	 indoxyl	
sulphate	after	48	h,	with	and	without	chloroquine.	B:	Graph	showing	densitometry	of	LC3BII	band	relative	to	that	
of	 GAPDH	 at	 increasing	 concentrations	 of	 indoxyl	 sulphate	 at	 48	 h	 without	 chloroquine.	 C:	 Graph	 showing	
densitometry	of	LC3BII	band	relative	to	that	of	GAPDH	at	 increasing	concentrations	of	 indoxyl	sulphate	at	48	h	
with	 chloroquine.	 D:	 Graph	 showing	 densitometry	 of	 p62	 band	 relative	 to	 that	 of	 GAPDH	 at	 increasing	









thus	 providing	 a	 means	 of	 monitoring	 the	 degree	 of	 autophagy	 induction.	 It	 should	 be	








(also	 known	 as	 sirolimus	 and	 marketed	 under	 the	 trade	 name	 Rapamune)	 after	 renal	





an	 interesting	 finding	 (one	might	expect	 the	 reverse),	 and	 is	 corroborated	by	 the	work	of	
Ramirez-Peinado	 et	 al.,	 who	 found	 that	 depriving	 cells	 of	 glucose	 did	 not	 cause	 them	 to	
engage	in	pro-survival	autophagy132.	The	authors	point	out	that	previous	groups	claiming	an	
autophagy-inducing	 role	 for	 glucose	 had	 deprived	 cells	 of	 other	 factors	 (such	 as	 serum)	
	 82	








Again,	 this	 was	 of	 great	 significance	 to	 further	 experiments,	 as	 it	 meant	 that	 anything	
influencing	 the	 AMPK	 pathway	 (e.g.	 nutritional	 intake)	would	 have	 to	 be	 controlled	 for	 if	
possible,	or	at	least	taken	into	consideration	in	the	analysis.	
	
IS	 (an	 established	 uraemic	 toxin)	 appeared	 to	 stimulate	 autophagy,	 with	 the	 greatest	
difference	versus	control	noticeable	at	48	h	with	25	µg/ml	of	IS.	Interestingly,	this	is	a	level	
detectable	 in	 the	 plasma	 of	 dialysis	 patients134.	 Whilst	 not	 wholly	 representative	 of	 the	












58.	All	animals	were	 fasted	 for	24	h	 (to	correct	 for	differences	 in	caloric	 intake)	and	given	
chloroquine	10	mg/kg	i.p.	4	h	prior	to	sacrifice.		
	
Both	 adenine-diet	 and	 5/6	 nephrectomy	 rats	 had	 significantly	 higher	 serum	 urea	 and	
creatinine	levels	than	controls	(Figure	9).	As	previously	described,	adenine-diet	animals	were	








































Figure	 9:	 Serum	 urea	 and	 creatinine	 levels	 in	 control,	 adenine-diet	 and	 5/6	 nephrectomy	 rats.	 A:	 Serum	
creatinine	in	control	and	adenine-diet	rats	(****	denotes	p	value	<	0.0001	by	unpaired	t	test,	n	=	6).	B:	Serum	



















visually	 true	 for	 LC3A-II	 (another	 isoform	 of	 LC3)	 and	 beclin-1	 (a	 key	 protein	 involved	 in	
assembly	of	the	autophagy	machinery).	Interestingly,	less	p62	was	detected	in	the	hearts	from	
uraemic	 than	 that	 found	 in	 control	 rats	 (as	 measured	 by	 densitometry).	 This	 may	 not	
necessarily	be	a	contradictory	result	 (if	accurate),	as	 it	may	reflect	 incomplete	blockade	of	
autophagy	by	chloroquine	(thus	the	greater	levels	of	LC3A	and	B-II	and	beclin-1,	and	lower	


























bands	reactive	with	 LC3A	and	B,	p62,	beclin	1	and	GAPDH	in	protein	 isolates	of	 cardiac	tissues	from	control	and	











5/6	 nephrectomy	 and	 sham	 procedure	 control	 rats	 were	 created	 using	 methodology	
described	in	Chapter	3,	3.3,	page	58.	Both	groups	were	fasted	for	24	h,	with	chloroquine	10	
mg/kg	i.p.	given	4	h	before	sacrifice.	Hepatic	tissue	was	harvested	and	snap	frozen.	Uraemia	




fasted	 for	 24	 h	 and	 given	 chloroquine	 than	 in	 those	with	 normal	 renal	 function	who	 had	
undergone	a	sham	procedure	(p	=	0.029	by	Mann-Whitney	U	test,	n	=	4).	This	was	also	visually	
true	for	LC3A-II	(another	isoform	of	LC3).	More	p62	was	also	detected	in	5/6	nephrectomy	rat	





























mg/kg	 i.p.	 given	 4	 h	 before	 being	 sacrificed.	 Hepatic	 tissue	 was	 harvested	 and	 snap	 frozen.	 Uraemia	 was	
confirmed	 by	 serological	 testing.	 Proteins	 were	 resolved	 by	 immunoblot.	A:	 Western	 blot	 showing	 bands	



















The	 expression	 of	 p53	 and	 p16Ink4a	 was	 significantly	 increased	 in	 the	 heart	 of	 24-month	
compared	to	2-month	old	mice	(in	fact	these	markers	of	senescence	were	barely	detectable	






























Figure	 12:	Markers	 of	 senescence	 in	 cardiac	 and	 hepatic	 tissues	 of	 elderly	 and	 young	mice.	A:	Western	 blot	
showing	bands	reactive	with	p53	and	GAPDH	in	protein	isolates	of	cardiac	tissues	from	fasted	young	and	elderly	
mice.	B:	Western	blot	showing	bands	reactive	with	p53	and	GAPDH	in	protein	isolates	of	liver	tissues	from	fasted	





























































Whilst	 not	 achieving	 statistical	 significance,	 LC3B-II	 (and	 LC3A-II	 and	 beclin-1)	 expression	




















































































































wisdom	 that	 changes	 in	 autophagy	 take	 place	 at	 post-translational	 level108.	 Nonetheless,	
those	that	were	altered	are	of	interest.	
	
Cxcr4	 (-2.58	 fold,	 p	 =	 0.019958	 by	 Student’s	 t-test)	 encodes	 for	 the	 chemokine	 receptor	
CXCR4,	 which	 is	 expressed	 in	 cardiac	myocytes	 and	 fibroblasts136.	Mice	 heterozygous	 for	
CXCR4	(Cxcr4+/-)	have	significantly	reduced	CXCR4	cellular	surface	expression	than	wild-type	
mice.	 Cxcr4+/-	 mice	 demonstrate	 reduced	 infarct	 size	 at	 4	 weeks	 after	 experimental	
myocardial	 infarction	 (MI)	 compared	 with	 controls.	 This	 is	 associated	 with	 altered	
inflammatory	 cell	 recruitment,	 decreased	 neutrophil	 content,	 and	 delayed	 monocyte	
infiltration.	 However,	 basal	 coronary	 blood	 flow	 and	 its	 recovery	 after	 MI	 are	 impaired,	
paralleled	by	reduced	angiogenesis,	myocardial	vessel	density,	and	endothelial	cell	count.	The	










Bcl2l1/Bcl-xL	 suppresses	 autophagy,	 whereas	 in	 conditions	 of	 hypoxia	 it	 induces	 it	 (as	
mentioned	in	Chapter	1,	1.4.1,	page	27),	increasing	mitochondrial	turnover	and	decreasing	
apoptosis139.	From	this	 it	might	be	 inferred	 that	 the	upregulation	of	Bcl2l1	 in	 the	uraemic	
heart	 acts	 to	 increase	 mitochondrial	 turnover	 and	 thus	 generate	 energy	 and	 prevent	
apoptosis	 under	 hypoxic	 conditions.	 This	 idea	 is	 consistent	with	 the	 findings	 of	 increased	








Lmnb2	 is	 particularly	 interesting,	 as	 it	 encodes	 for	 lamin	 B2,	 a	 protein	 involved	 in	 the	
formation	of	the	nuclear	envelope140.	Lamin	A,	a	nuclear	envelope	protein	encoded	by	Lmna	
(itself	expressed	–	2.42	fold	in	adenine-diet	rat	cardiac	tissue,	p	=	0.004299)	,	is	the	protein	
truncated	 in	 Hutchinson-Gilford	 progeria141,	 a	 condition	 which	 demonstrates	 striking	
similarities	to	the	uraemic	phenotype,	especially	with	regards	to	the	cardiovascular	system:	
Hutchinson-Gilford	progeria	sufferers	die	at	a	mean	age	of	14,	primarily	of	stroke	and	MI,	and	











proteins,	 which	 are	 increased	 in	 a	 number	 of	 inflammatory	 and	 autoimmune	 states144.	
















































































































were	 fed	 either	 an	 adenine	 or	 control	 diet,	 fasted	 for	 24	 h,	 and	 half	 given	 10	 mg/kg	
chloroquine	i.p.	4	hours	before	being	sacrificed.	Tissues	were	sectioned,	stained	with	DAPI,	
and	viewed	under	a	fluorescent	microscope.	Punctae	fluorescing	under	a	GFP	but	not	RFP	




Interestingly,	 whilst	 the	 number	 of	 GFP-LC3	 punctae	 appeared	 to	 be	 greater	 in	 fasted	
adenine-diet	mouse	hearts	than	control-diet	mouse	hearts,	this	effect	was	cancelled	out	by	
the	 addition	of	 chloroquine.	 This	 could	 be	 interpreted	 as	 showing	 that	 adenine-diet	mice	
actually	exhibited	less	autophagy,	the	greater	number	of	GFP-LC3	punctae	seen	in	mice	who	
had	 not	 received	 chloroquine	 being	 the	 result	 of	 inhibition	 of	 autolysosome	 breakdown,	
rather	than	increased	autophagosome	formation.	However,	it	is	somewhat	odd	that	LC3-GFP	
numbers	 appear	 to	 be	 less	 (albeit	 insignificantly)	 in	 the	 chloroquine-treated	 animals.	 This	





































































is,	 in	 fact,	greater	 in	 the	elderly.	This	 is	 consistent	with	 the	 findings	of	Sengstock	et	al.	of	










Staining	 for	 β-galactosidase	 in	 the	 hearts	 and	 livers	 of	 control	 and	 uraemic	 rats	 was	
unsuccessful.	 It	 is	well	 established	 that	 senescent	 cells	 are,	 in	 actual	 fact,	 quite	 scarce	 in	
tissues18,	and	it	is	quite	possible	that	they	are	effectively	undetectable	in	only	two-month	old	
































did	 not	 achieve	 statistical	 significance).	 A	 marker	 of	 autophagy	 activity	 was	 significantly	
increased	 in	hepatic	 tissues	 in	a	5/6	nephrectomy	rodent	model	of	uraemia.	Although	the	
transcription	of	autophagy-related	genes	in	the	hearts	of	uraemic	rats	did	not	differ	greatly	
from	 that	 in	healthy	animals,	 the	genes	 that	were	more	or	 less	expressed	 suggest	a	 ‘pro-
autophagy’	 state	 at	 a	 transcriptional	 level	 in	 the	 uraemic	 heart,	 though	 this	 is	 likely	















IS	 (a	 recognised	uraemic	 toxin131)	appeared	 to	 stimulate	autophagy	 in	H9c2	cells	with	 the	
greatest	difference	versus	control	noticeable	at	48	h	with	25	µg/mL	of	IS.	Interestingly	this	is	











toxins	 actually	 have	 an	 inhibitory	 effect	 on	 autophagy,	 though	 these	 would	 not	 be	
representative	of	IS	concentrations	in	patients	with	CKD,	and	therefore	of	little	translational	
interest.	Additionally,	 it	must	be	 taken	 into	account	 that	24	h	and	48	h	of	exposure	 to	 IS	
represents	an	acute	insult,	therefore	this	may	not	be	representative	of	the	chronic	uraemic	
state.	It	is	quite	possible	that	autophagy	is	initially	upregulated	then	either	remains	steady	or	



















autophagy	 a	 way	 might	 need	 to	 be	 found	 to	 control	 for	 nutritional	 deficiencies	 without	
introducing	an	acute	stressor.	This	is	very	hard	to	achieve	given	that	anorexia	and	cachexia	
are	 features	 of	 many	 chronic	 disease	 states.	 However,	 human	 studies	 have	 shown	 that	
hypoxia-induced	upregulation	of	cardiac	autophagy	may	be	greater	 in	older	subjects151,	as	





































autophagy	 has	 been	 partially	 characterised,	 and	 a	 significant	 number	 of	 genes	 encoding	


















It	 should	be	noted	 that	 the	 animals	 in	 this	 experiment	were	not	 fasted,	 thus	 it	would	be	
interesting	to	repeat	it	in	fasted	conditions	to	determine	whether	there	is	a	change	in	Bcl2l1	
expression.	Again,	this	would	further	elucidate	whether	uraemia	affects	basal	and	inducible	




















in	 elderly	 (and	 by	 expectation	 senescent)	 rodents.	 The	 intention	 was	 to	 characterise	 an	
‘elderly’	pattern	of	protein	expression,	against	which	 that	 in	uraemia	could	be	compared.	
Elderly	 (twenty-four	 month-old)	 mice	 were	 used	 for	 these	 experiments	 as	 they	 were	
considerably	cheaper	than	rats,	and	markers	of	both	autophagy	and	senescence	are	highly	
conserved	 across	 species50,2.	 p53	 and	 p16Ink4a	 were	 chosen	 as	markers	 of	 senescence	 for	
immunoblot	 studies	 due	 to	 their	 consistent	 expression	 with	 ageing	 in	 most	 tissues	 and	
species22.	Unfortunately,	it	was	very	difficult	to	find	an	effective	antibody	to	p16Ink4a	(as	has	








nor	 in	 hepatic	 tissue	 from	 5/6	 nephrectomy	 and	 control	 rats.	 Experimental	 and	 control	
animals	were	 the	 same	age;	 therefore,	 this	was	not	 a	 confounder.	 Thus	 a	 corollary	 of	my	
previous	statement	regarding	the	utility	of	p53	expression	in	predicting	advanced	age	would	
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be	 that	 uraemia	 does	 not	 increase	 senescence	 in	 cardiac	 tissues	 in	 rats.	 However,	 p53	
expression	is	only	one	measure	of	senescence,	thus	this	cannot	be	seen	as	definitive	evidence	
that	senescence	is	not	increased	in	uraemia.	Additionally,	as	has	been	previously	discussed,	it	
remains	unclear	 as	 to	whether	 senescence	has	 a	 causative	 role	 in	 ageing,	 or	 is	merely	 an	
associated	phenomenon.	
	



















pertaining	 to	 the	 general	 state	 of	 ageing	 in	 the	 uraemic	 heart.	 	 Whilst,	 once	 again,	 this	
information	 needs	 to	 be	 corroborated	 by	 translational	 and	 post-translational	 work,	 the	
cumulative	evidence	points	 to	a	state	of	accelerated	ageing	and	 ischaemia	 in	 the	uraemic	
heart,	 in	 which	 survival	 mechanisms	 such	 as	 autophagy	 are	 upregulated	 by	 way	 of	






and	senescence,	 the	 former	 in	vitro	and	 in	vivo,	and	the	 latter	 in	vivo.	Both	processes	are	




upregulation	of	autophagy	 in	 cardiac	cells	exposed	 to	a	uraemic	 toxin,	and	 in	cardiac	and	
hepatic	 tissues	 from	 fasted,	 uraemic	 animals.	 Additionally,	 there	were	 differences	 (albeit	
expectedly	few)	in	the	transcription	of	autophagy-related	genes	in	non-fasted	uraemic	hearts	
that	may	be	 interpreted	to	demonstrate	an	upregulation	of	autophagy	at	a	transcriptional	








known	 to	 be	 increased	 in	 conditions	 of	 stress,	 e.g.	myocardial	 ischaemia130	 and	 oxidative	





become	 dogma	 that	 autophagy	 declines	 with	 cardiac	 ageing,	 based	 on	 indirect	 evidence	
provided	by	lipofuscin	and	ROS	studies	in	the	aged	heart103,154,155,156	,	there	is	much	published	
material	that	contradicts	this151,157.	Of	particular	note	is	the	study	by	Boyle	et	al.	of	ageing-
related	 cardiomyopathy	 in	 mice158.	 Serial	 echocardiography	 was	 performed	 on	 the	 same	
cohort	of	mice	every	3	months,	demonstrating	an	 increase	 in	 left	 ventricular	hypertrophy	
(LVH)	 and	 fibrosis.	 Electron	 microscopy	 of	 left	 ventricular	 tissue	 showed	 an	 increase	 in	
autophagic	 vacuoles	 in	 cardiac	myocytes	 in	 the	 older	mice,	 with	 increased	 expression	 of	
beclin-1	and	an	increased	LC3II	to	I	ratio.	Markers	of	apoptosis	were	increased	in	the	elderly	




















without	 intraperitoneal	 chloroquine.	 This	 would	 assess	 both	 the	 extent	 of	 induction	 and	
successful	 completion	 of	 both	 basal	 and	 reactive/inducible	 autophagy.	 Based	 on	 my	
experiments	I	would	pursue	immunoblotting	and	fluorescence	microscopy	for	LC3	as	the	best	
measures	of	autophagy	(LC3-GFP	transgenic	animals	offer	another	means	of	immunoblotting	
for	 autophagy,	 the	 amount	 of	 free	 GFP	 fragment	 indicating	 the	 amount	 of	 completed	
autophagic	flux108).	Senescence	is	best	assessed	by	immunoblotting	for	p53	and	(with	a	good	
antibody)	 p16Ink4a,	 both	 of	 which	 could	 simultaneously	 be	 assessed	 alongside	markers	 of	




alternative	 pathways	 of	 ageing	 to	 investigate.	 Experiments	 to	 investigate	 the	 relationship	
between	autophagy	and	senescence	might	be	to	inhibit	(for	instance	using	3-methyladenine,	
3-MA)	or	induce	(using	rapamycin)	autophagy,	then	assess	the	impact	this	has	on	senescence.	









of	 cardiac	 ageing	 (for	 instance	 a	 decrease	 in	 cardiac	 hypertrophy	 on	 echocardiogram),	
alongside	molecular	evidence	of	increased	autophagy	and	senescence.	Additional	methods	








kidney	 disease	 are	 physiologically	 much	 akin	 to	 the	 elderly	 (regardless	 of	 the	 molecular	
mechanisms	 underpinning	 this),	 and	 measures	 such	 as	 frailty	 scores	 and	 fall	 risks	 might	
perhaps	 be	 better	 predictors	 of	 outcomes	 than	 investigations	 employed	 in	 non-affected	
persons,	interventions	such	as	exercise	may	be	of	great	benefit,	and	a	general	approach	that	
acknowledges	a	degree	of	progeria	likely	to	prove	most	beneficial.		
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